Esperion Therapeutics, Inc. (NASDAQ: ESPR) a clinical-stage
biopharmaceutical company focused on developing and commercializing
first-in-class, oral, low-density lipoprotein cholesterol
(LDL-cholesterol) lowering therapies for the treatment of
hypercholesterolemia and other cardiometabolic risk markers, today
announced it will host a conference call and webcast to report
operational and financial results from the second quarter 2014.
REDWOOD CITY, CA --
NEW YORK (MarketWatch) -- 21st Century Fox shares surged almost 10% in after-hours trade Tuesday and Time Warner Inc. shares (TWX) tumbled 10.6%, after Fox said it is withdrawing its proposal to buy Time Warner.
Air Transport Services Group, Inc. (Nasdaq: ATSG), the leading provider
of medium wide-body aircraft leasing, air cargo transportation and
related services, today reported consolidated financial results for the
quarter ended June 30, 2014.
WALNUT CREEK, CA --
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.